Skip to main content
Displaying 1 - 12 of 35
Display:
12
24
48
Metabolism, Alcohol & Toxicity
Pathophysiological analysis of MASH: targetting clinical manifestations
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: Addressing MASH as a liver manifestation of the metabolic disease (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Approaching MASH as a metabolic disease with the need for holistic therapy
Webcasts
View
Metabolism, Alcohol & Toxicity
Panel Discussion
Webcasts
View
Metabolism, Alcohol & Toxicity
Summary and Closing remarks
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
The evolving goals of PBC treatment
Webcasts
View
Immune-Mediated and Cholestatic Diseases
AdvanzPharma: Shifting Paradigms in PBC Management (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Demonstrating clinical outcomes through real- world data
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Questions and answers
Webcasts
View
Metabolism, Alcohol & Toxicity
Navigating MASH patient care
Webcasts
View
Pagination
Current page
1
Page
2
Page
3
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy